River Global Investors LLP Sells 10,971 Shares of Stericycle, Inc. (NASDAQ:SRCL)

River Global Investors LLP decreased its holdings in shares of Stericycle, Inc. (NASDAQ:SRCL - Free Report) by 39.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,882 shares of the business services provider's stock after selling 10,971 shares during the period. River Global Investors LLP's holdings in Stericycle were worth $1,030,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Clearstead Trust LLC bought a new position in Stericycle during the first quarter worth about $25,000. Headlands Technologies LLC bought a new position in shares of Stericycle in the first quarter valued at approximately $44,000. International Assets Investment Management LLC bought a new position in shares of Stericycle in the second quarter valued at approximately $45,000. Quest Partners LLC raised its stake in shares of Stericycle by 4,172.7% in the second quarter. Quest Partners LLC now owns 940 shares of the business services provider's stock valued at $55,000 after acquiring an additional 918 shares during the last quarter. Finally, Summit Securities Group LLC bought a new position in shares of Stericycle in the second quarter valued at approximately $58,000. Institutional investors own 98.82% of the company's stock.

Stericycle Price Performance

SRCL stock remained flat at $61.98 during trading on Friday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.13 and a current ratio of 1.20. The stock's 50 day moving average is $61.13 and its 200 day moving average is $57.24. Stericycle, Inc. has a 52 week low of $37.78 and a 52 week high of $61.99. The stock has a market capitalization of $5.75 billion, a price-to-earnings ratio of 163.11, a PEG ratio of 3.38 and a beta of 1.10.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Stericycle in a research note on Monday, November 4th. They issued a "hold" rating for the company. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $74.00.

Stericycle Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.